Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
OrbiMed’s largest-ever Asian fund contributes to $3B war chest
OrbiMed has raised $3 billion to place a fresh round of bets on biotechs and life sciences companies in the U.S., Europe and Asia.
Nick Paul Taylor
Oct 15, 2026 9:18am
OMass’ $310M raise fuels goal to become ‘Britain’s Big Biotech’
Oct 15, 2026 2:00am
Fierce Biotech Fundraising Tracker '26: OMass, Soufflé & more
Oct 13, 2026 8:00am
TCGX launches $600M fund to bankroll Asian biotechs
Oct 7, 2026 10:21am
Matchpoint nets $150M series B to take covalent med into clinic
Oct 7, 2026 8:15am
Forbion’s ‘landmark’ €2.3B fundraise to benefit 30 biotechs
Oct 6, 2026 8:12am
